Salix Did Its Part In Developing Napo Drug, Atty Argues

Law360, New York (August 22, 2013, 6:50 PM EDT) -- Salix Pharmaceuticals Inc. took all reasonable best efforts to help Napo Pharmaceuticals Inc. develop an anti-diarrhea drug, Salix's attorney told a New York state judge during a hearing Thursday, arguing that it didn't have to develop the drug for other uses.

The drug is called crofelemer, a botanically derived anti-diarrhea medication, and the U.S. Food and Drug Administration eventually approved it for use with certain HIV/AIDS patients in 2012 after Napo brought Salix on board to revive its stalled efforts at developing the patented medication. ...
To view the full article, register now.